The global surgical robots market size was valued at USD 10.10 Billion in 2023 and it is projected to reach USD 37.36 Billion by 2032, growing at a CAGR of 16.5% during the forecast period (2024–2032).
Surgical robots have undergone a paradigm shift as a result of recent technological advancements in data analysis systems, 3D imaging, motion sensors, data recorders, robotic controlled catheters, remote navigation technologies, high-definition tiny cameras, and other surgical accessories. These developments make it possible to create cutting-edge applications for already-existing platforms. They speed up the creation of disruptive technologies, which are anticipated to drive the surgical robots market growth during the projected period. Additionally, it is projected that demand for better patient outcomes will increase during the forecast period due to robotic surgery's superior outcomes and lower cost than conventional methods.
One of the significant causes projected to accelerate the deployment of surgical robots in the healthcare sector is the rise in the frequency of knee and hip replacement operations. All forms of arthritis, diseases that degenerate bone, and osteoporosis are some significant conditions impacting the joints. The number of individuals needing knee and hip replacement surgery has increased as a result of these disorders becoming more prevalent. In March 2017, the University of California Regents reported that, compared to 2005, total knee and hip replacements are expected to have increased by more than 600% and over 2000%, respectively, in the United States by 2030.
According to Burden of Musculoskeletal Diseases in the United States, 126 million Americans experienced musculoskeletal issues in 2017. According to another survey, osteoarthritis, which affects over 52 million Americans 65 and older, is the most prevalent musculoskeletal ailment. Other variables anticipated to contribute to the increase in demand for such surgeries and the high need for surgical robots include the rising incidence of obesity, which causes increased wear and tear on joints, and the rapidly aging population with longer life expectancy.
Surgeons have used robotic-assisted surgical tools to carry out a variety of operations through tiny incisions. This surgery helps reduce discomfort, scars, infections, and recovery time compared to conventional treatments. It also helps to prevent blood loss. The F.D.A. is aware of the media reports and scientific literature that describe hospital systems and surgeons using these devices for mastectomy. Still, according to data published in February 2019, the effectiveness and safety of using surgical robots in mastectomy procedures and for the treatment and prevention of cancer have not yet been established.
Robotic surgical systems are promoted as a safer alternative to conventional procedures. However, they come with a number of dangers, including mechanical and human error. These systems' numerous parts could break down, which would cause additional problems. Patients and medical professionals aware of the hazards may choose open surgery over robotic surgery.
Intuitive Surgical, the current market leader, will likely face competition from other big healthcare players, which will cause several changes in the surgical robots market. Auris Health, a provider of robotic technology platforms, was bought by Johnson & Johnson subsidiary Ethicon in April 2019. The company's dedication to fighting lung cancer is anticipated to be strengthened by this acquisition, enabling it to offer digital surgery in more surgical specialties.
In addition, Mazor X Stealth Edition was made possible by the union of Medtronic's spine implants, Mazor's robotic-assisted surgery systems, and 3D imaging and navigation technologies. Senhance, a robotic device from TransEnterix, obtained F.D.A. certification for laparoscopic abdominal surgery in October 2018. Additionally, in February 2018, Orthotaxy, a developer of software-enabled surgery solutions, was purchased by Apsis S.A.S., the French affiliate of Johnson & Johnson. Johnson & Johnson is working to develop the next generation of user-friendly robot-assisted orthopedic surgery solutions in various care settings and cost and time-effective.
| Study Period | 2020-2032 | CAGR | 16.5% |
| Historical Period | 2020-2022 | Forecast Period | 2024-2032 |
| Base Year | 2023 | Base Year Market Size | USD 10.10 Billion |
| Forecast Year | 2032 | Forecast Year Market Size | USD 37.36 Billion |
| Largest Market | North America | Fastest Growing Market | Asia Pacific |
The global surgical robots market share is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
North America is the most significant global surgical robots market shareholder and is expected to grow at a CAGR of 18.60% during the forecast period. Developing surgical techniques and healthcare resources for diverse illnesses is essential to market drivers. The demand for robotic-assisted surgeries is increasing due to better results compared to open procedures, shorter hospital stays, and recuperation times for children. Additionally, advances in instrument downsizing are projected to permit ideal working conditions in confined spaces, which is anticipated to support market growth. It is anticipated that rigorous research and development into ergonomic workstations will accelerate clinical acceptance of innovative minimally invasive surgical procedures and shorten learning curves.
Asia-Pacific is expected to grow at a CAGR of 23.10% during the forecast period. In the upcoming years, the Asia-Pacific region is anticipated to experience strong G.D.P. growth, primarily driven by expansion in India, China, Singapore, Indonesia, and Australia. One of the main factors predicted to propel the market for surgical robots is the rise in government efforts to encourage healthcare institutions and other providers to utilize technologically advanced medical devices and systems. Thailand, China, India, and Malaysia are the rising markets in the Asia-Pacific region for technology adoption. In contrast, Japan, Singapore, Australia, and South Korea have implemented technology significantly in the healthcare sector.
Europe is expected to grow significantly over the forecast period. Key market growth drivers in the region include the availability of well-established healthcare infrastructure and appealing reimbursement rules that reduce patients' out-of-pocket costs. Additionally, it is projected that regional robotics research that is now underway would fuel market expansion over the projection period. For instance, research studies supported by the E.U. are encouraging the development of novel, less invasive, and cost-effective micro-robotics technology to reduce complications from complicated operations. The SPORT Surgical System from Titan Medical was deployed in Europe's Institut Hospitalo-Universitaire de Strasbourg (I.H.U.) research center in December 2017 by Titan Medical, Inc. Furthermore, robotic-assisted operations and efficient techniques that produce little scarring, lower health risks, and quicker patient recovery are replacing swift technological advances in surgical treatments.
Brazil, Mexico, and Venezuela are the principal financial backers of the economies of Latin America. Despite ongoing efforts to increase healthcare access and treatment levels, the country's healthcare sector needs to be better developed. Increasing rates of osteoporosis, the ease with which modern technologies and robots are available, and the prevalence of chronic diseases are some factors propelling market expansion in this region. Due to a lack of awareness and a developing healthcare system, the Middle East and Africa currently have the smallest market share. However, the region's high cancer incidence and absence of knowledgeable medical personnel are increasing the demand for robotic-assisted procedures. Despite the industry's small size, more robotic procedures are being performed, which is anticipated to drive market expansion over the forecast period.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Based on application, the global surgical robots market share is bifurcated into orthopedics, neurology, urology, gynecology, and others.
The global surgical robots market is segmented by application.
The orthopedics segment is the highest contributor to the market and is expected to grow at a CAGR of 16.10% during the forecast period. The prevalence of musculoskeletal illnesses, such as osteoarthritis, osteoporosis, rheumatoid arthritis, and lower back pain, is expected to rise, along with market rivalry. For instance, Stryker introduced more than 650 Mako surgical robots in renowned hospitals worldwide as of June 2019. These Mako surgical robots carried out more than 76,900 knees and hip replacement procedures in 2018. Additionally, in 2019 the 510(k) F.D.A. approved Zimmer Biomet's Rosa whole knee surgery platform for spine and knee surgeries. Thus, the increased rivalry is projected to fuel market expansion throughout the projection period. Increasing demand for minimally invasive procedures will likely fuel the surgical robots market during the forecast period because they are less time-consuming and successful.
Surgical robots help doctors complete complex surgeries with less pain and scarring for the patients thanks to their enhanced control, agility, and flexibility. Robotic surgery offers various advantages for doctors and patients, including a lower risk of infection, even though the results and quality of conventional operations have not diminished noticeably. According to data compiled by B.B.C. Sport, there were an increase in anterior cruciate ligament (A.C.L.) injuries among Premier League soccer players between 2015 and 2017. These injuries include medial collateral ligament (MCL) tears and lateral collateral ligament (L.C.L.) tears. One of the main factors driving the development of robot-aided operations and assisting market expansion is the trend of increasing A.C.L. injuries among athletes.
Rising acceptance and use of minimally invasive procedures due to shorter hospital stays, less blood loss, minimal scarring, and affordable and technologically advanced surgical robot launches by new market participants are driving the surgical robots market growth. The market for surgical robots is driven by the expanding demand for automation in the healthcare sector and a changing trend toward highly advanced robotic procedures. Robotic systems have the technological ability to improve surgical procedures in terms of effectiveness and safety through various means, ranging from indirect support of surgeons during complex parts of the operation to complete substitution of manual skills required by surgical tasks.
Neurosurgery is one of the most delicate and demanding surgical specialties due to the limited mobility required by advanced minimally invasive procedures. The growing prevalence of neurological illnesses and the rising need for minimally invasive methods of performing delicate brain surgeries are key factors projected to propel the market. For instance, surgeons frequently employ the ROSA ONE Brain robotic platform for minimally invasive brain treatments. Additionally, in March 2019, Taiwan-based Brain Navi Biotechnology created NaoTrac, a robotic surgical system for brain surgery with autopilot navigation.
The introduction of robotic surgical systems in urology and the necessity for accuracy when carrying out delicate urological treatments are vital factors projected to boost the market. For instance, robots are frequently employed in procedures like nephrectomy, cystectomy, and prostatectomy. Surgical robots during prostatectomy have demonstrated notable success in retaining erectile function or sparing nerves. In addition, nephrectomy performed using surgical robots offers faster operating times, less blood loss, and shorter hospital stays than traditional open operations. Due to the delicate nature of most urological procedures, surgical robots have now been adopted as the norm. Therefore, these factors are projected to fuel the market throughout the forecast period.
Surgical robots are increasingly used to treat gynecologic conditions such as endometriosis, pelvic organ prolapse, cervical cancer, ovarian cancer, and uterine cancer. Furthermore, it is predicted that during the forecast period, there will be a rise in the need for minimally invasive techniques for carrying out complicated gynecologic surgery. According to a 2016 study in Frontiers in Surgery, the quantity of surgeries utilizing robots has grown dramatically since the launch of the Da Vinci Surgical System for gynecological treatments in 2005.
